oncology medicine targeted therapy

💊 Svitinib 12.5 mg Capsule | Sunitinib | Oncology Therapy | Export Supplier Svitinib 12.5 mg Capsule contains Sunitinib, a tyrosine kinase inhibitor used in the treatment of certain types of cancer. It works by blocking specific proteins involved in tumor growth and angiogenesis under medical supervision. 🔹 Product Category Oncology Medicine (Targeted Therapy) 🔹 Composition Sunitinib 12.5 mg 🔹 Indications ✔ Renal Cell Carcinoma (Kidney Cancer) ✔ Gastrointestinal Stromal Tumor (GIST) ✔ Pancreatic Neuroendocrine Tumors 🔹 Key Benefits ✔ Targeted anti-cancer therapy ✔ Inhibits tumor growth pathways ✔ Oral administration for patient convenience ✔ Clinically established treatment option 🔹 Dosage & Administration ✔ Oral capsule ✔ As prescribed by oncologist ✔ Treatment cycles as per protocol 🔹 Packaging ✔ Capsule / Blister Packaging ✔ Export-Ready Packaging Available ✔ Bulk Supply Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Chicago, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ Targeted Cancer Therapies ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 📧 Email ✉️ sales@pacificmedicines.com